Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era
Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding...